Clinical Trial Update: Safety of Continuing HER-2 Directed Therapy in Overt Left Ventricular Dysfunction [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating the safety of continuing HER-2 directed therapy in breast cancer patients with overt left ventricular dysfunction.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Heart Failure

Snippet

Sponsor: Population Health Research Institute | Conditions: Breast Cancer, Heart Failure | Phase 2 | Status: RECRUITING